1. Home
  2. PSHG vs CTSO Comparison

PSHG vs CTSO Comparison

Compare PSHG & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Performance Shipping Inc.

PSHG

Performance Shipping Inc.

HOLD

Current Price

$1.80

Market Cap

20.9M

ML Signal

HOLD

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$0.37

Market Cap

23.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PSHG
CTSO
Founded
2010
1997
Country
Greece
United States
Employees
N/A
N/A
Industry
Marine Transportation
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.9M
23.9M
IPO Year
2010
2008

Fundamental Metrics

Financial Performance
Metric
PSHG
CTSO
Price
$1.80
$0.37
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$5.38
AVG Volume (30 Days)
39.4K
54.1K
Earning Date
05-26-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
65.79
EPS
N/A
N/A
Revenue
N/A
$22,503,908.00
Revenue This Year
$49.57
$10.34
Revenue Next Year
$2.73
$22.41
P/E Ratio
$1.59
N/A
Revenue Growth
N/A
48.53
52 Week Low
$1.61
$0.35
52 Week High
$2.58
$1.22

Technical Indicators

Market Signals
Indicator
PSHG
CTSO
Relative Strength Index (RSI) 56.44 44.17
Support Level $1.71 $0.36
Resistance Level $1.89 $0.40
Average True Range (ATR) 0.07 0.03
MACD 0.01 0.00
Stochastic Oscillator 60.42 30.00

Price Performance

Historical Comparison
PSHG
CTSO

About PSHG Performance Shipping Inc.

Performance Shipping Inc is a shipping company. The company is a provider of shipping transportation services through the ownership of tanker vessels. The company's vessels are employed on time charters with liner companies carrying container vessels and cargo along various shipping routes. It owns and operates Aframax and Suezmax tanker vessels.

About CTSO Cytosorbents Corporation

CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.

Share on Social Networks: